Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria

NCT04317261 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04317261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04317261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
March 1, 2020
Enrollment
181 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria